EU Regulators Find Wegovy, Ozempic Link to Rare Vision Loss

Narrative A

These findings highlight safety signals that demand immediate attention from regulators and prescribers. The doubling of risk for severe eye conditions that can cause permanent blindness cannot be dismissed, even if the absolute numbers appear small. Patients deserve complete transparency about these risks before starting treatment.